Maxim Tsypin

1 Patent

• US122303982025

  Predictive Test for Patient Benefit from Antibody Drug Blocking Ligand Activation of the T-cell Programmed Cell Death 1 (PD-1) Checkpoint Protein and Classifier Development Methods

  BIODESIX, Inc.

  0 cites